EP12.01-18 Validation of the ALK-Brain Prognostic Index (ALK-BPI) Model in Patients with ALK-rearranged Non-small Cell Lung Cancer and Brain Metastases
Journal of Thoracic Oncology(2023)
摘要
Anaplastic Lymphoma Kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) has been correlated with substantial incidence of brain metastases (BM). Various prognostic scores have been developed, though mostly before the era of targeted therapies. We have previously proposed the ALK-Brain Prognostic Index (ALK-BPI) as a prognostication tool for patients with BM treated with ALK inhibitors. The aim of this study was to validate its performance in an external clinical cohort.
更多查看译文
关键词
alk-brain metastases,lung cancer,cell lung cancer,alk-bpi,alk-rearranged,non-small
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要